Back to Directory

Katie S. McCarthy

Email

kmccarthy@fhi360.org

Institution

FHI 360

Title

Clinical Research Associate

Address

FHI 360
359 Blackwell St.
Suite 200
Durham, NC 27701
United States of America

Request an Update

Affiliated Studies

IMPAACT 2034: Phase I Study of the Pharmacokinetics, Safety, and Acceptability of Pretomanid in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

Research Area

IMPAACT 2020: SMaRT Kids

DAIDS Number

Research Area

Study Status

P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents

DAIDS Number

Research Area

Study Status

Show All